Proapoptotic Function of the MET Tyrosine Kinase Receptor through Caspase Cleavage

REFERENCES

• Arakaki, N., Kazi J. A., Kazihara T., Ohnishi T., and Daikuhara Y.. 1998. Hepatocyte growth factor/scatter factor activates the apoptosis signaling pathway by increasing caspase-3 activity in sarcoma 180 cells. Biochem. Biophys. Res. Commun. 245:211–215.
   PubMed Web of Science ®Google Scholar
• Bae, S. S., Choi J. H., Oh Y. S., Perry D. K., Ryu S. H., and Suh P. G.. 2001. Proteolytic cleavage of epidermal growth factor receptor by caspases. FEBS Lett. 491:16–20.
   PubMed Web of Science ®Google Scholar
• Birchmeier, C., Birchmeier W., Gherardi E., and Vande Woude G. F.. 2003. Met, metastasis, motility and more. Nat. Rev. Mol. Cell. Biol. 4:915–925.
   PubMed Web of Science ®Google Scholar
• Bladt, F., Riethmacher D., Isenmann S., Aguzzi A., and Birchmeier C.. 1995. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376:768–771.
   PubMed Web of Science ®Google Scholar
• Bordeaux, M. C., Forcet C., Granger L., Corset V., Bidaud C., Billaud M., Bredesen D. E., Edery P., and Mehlen P.. 2000. The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J. 19:4056–4063.
   PubMed Web of Science ®Google Scholar
• Crepaldi, T., Prat M., Giordano S., Medico E., and Comoglio P. M.. 1994. Generation of a truncated hepatocyte growth factor receptor in the endoplasmic reticulum. J. Biol. Chem. 269:1750–1755.
   PubMedGoogle Scholar
• Di Renzo, M. F., Olivero M., Martone T., Maffe A., Maggiora P., Stefani A. D., Valente G., Giordano S., Cortesina G., and Comoglio P. M.. 2000. Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas. Oncogene 19:1547–1555.
   PubMed Web of Science ®Google Scholar
• Furge, K. A., Zhang Y. W., and Vande Woude G. F.. 2000. Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene 19:5582–5589.
   PubMed Web of Science ®Google Scholar
• Gandino, L., Longati P., Medico E., Prat M., and Comoglio P. M.. 1994. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase. J. Biol. Chem. 269:1815–1820.
   PubMed Web of Science ®Google Scholar
• Jeffers, M., Taylor G. A., Weidner K. M., Omura S., and Vande-Woude G. F.. 1997. Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol. Cell. Biol. 17:799–808.
   PubMed Web of Science ®Google Scholar
• Kosai, K., Matsumoto K., Nagata S., Tsujimoto Y., and Nakamura T.. 1998. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem. Biophys. Res. Commun. 244:683–690.
   PubMed Web of Science ®Google Scholar
• Lee, C. C., and Yamada K. M.. 1995. Alternatively spliced juxtamembrane domain of a tyrosine kinase receptor is a multifunctional regulatory site. Deletion alters cellular tyrosine phosphorylation pattern and facilitates binding of phosphatidylinositol-3-OH kinase to the hepatocyte growth factor receptor. J. Biol. Chem. 270:507–510.
   PubMedGoogle Scholar
• Lee, Z. H., Lee S. E., Kwack K., Yeo W., Lee T. H., Bae S. S., Suh P. G., and Kim H. H.. 2001. Caspase-mediated cleavage of TRAF3 in FasL-stimulated Jurkat-T cells. J. Leukoc. Biol. 69:490–496.
   PubMedGoogle Scholar
• Liu, Y., Sun A. M., and Dworkin L. D.. 1998. Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. Biochem. Biophys. Res. Commun. 246:821–826.
   PubMed Web of Science ®Google Scholar
• Llambi, F., Causeret F., Bloch-Gallego E., and Mehlen P.. 2001. Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J. 20:2715–2722.
   PubMed Web of Science ®Google Scholar
• Lorenzato, A., Olivero M., Patane S., Rosso E., Oliaro A., Comoglio P. M., and Di Renzo M. F.. 2002. Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion. Cancer Res. 62:7025–7030.
   PubMed Web of Science ®Google Scholar
• Maina, F., Hilton M. C., Ponzetto C., Davies A. M., and Klein R.. 1997. Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons. Genes Dev. 11:3341–3350.
   PubMedGoogle Scholar
• Maina, F., Pante G., Helmbacher F., Andres R., Porthin A., Davies A. M., Ponzetto C., and Klein R.. 2001. Coupling Met to specific pathways results in distinct developmental outcomes. Mol. Cell 7:1293–1306.
   PubMed Web of Science ®Google Scholar
• Mehlen, P., Rabizadeh S., Snipas S. J., Assa-Munt N., Salvesen G. S., and Bredesen D. E.. 1998. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395:801–804.
   PubMed Web of Science ®Google Scholar
• Nakamura, T. 1991. Structure and function of hepatocyte growth factor. Prog. Growth Factor Res. 3:67–85.
   PubMedGoogle Scholar
• Naldini, L., Weidner K. M., Vigna E., Gaudino G. K., Bardelli A., Ponzetto C., Narsimhan R. P., Hartmann G., Zarnegar R., Michalopoulos G., Birchmeier W., and Comoglio P. M.. 1991. Scatter factor and hepatocyte growth factor are undistinguishable ligands for the MET receptor. EMBO J. 10:2867–2878.
   PubMed Web of Science ®Google Scholar
• Park, M., Dean M., Kaul K., Braun M. J., Gonda M. A., and Vande Woude G.. 1987. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad. Sci. USA 84:6379–6383.
   PubMed Web of Science ®Google Scholar
• Paumelle, R., Tulasne D., Kherrouche Z., Plaza S., Leroy C., Reveneau S., Vandenbunder B., and Fafeur V.. 2002. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene 21:2309–2319.
   PubMed Web of Science ®Google Scholar
• Peschard, P., Fournier T. M., Lamorte L., Naujokas M. A., Band H., Langdon W. Y., and Park M.. 2001. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol. Cell 8:995–1004.
   PubMed Web of Science ®Google Scholar
• Petrelli, A., Gilestro G. F., Lanzardo S., Comoglio P. M., Migone N., and Giordano S.. 2002. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature 416:187–190.
   PubMed Web of Science ®Google Scholar
• Ponzetto, C., Bardelli A., Zhen Z., Maina F., dalla Zonca P., Giordano S., Graaziani A., Panayotou G., and Comoglio P. M.. 1994. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77:261–271.
   PubMed Web of Science ®Google Scholar
• Sakata, H., Takayama H., Sharp R., Rubin J. S., Merlino G., and LaRochelle W. J.. 1996. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ. 7:1513–1523.
   PubMedGoogle Scholar
• Schmidt, C., Bladt F., Goedecke S., Brinkmann V., Zschiesche W., Sharpe M., Gherardi E., and Birchmeier C.. 1995. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373:699–702.
   PubMed Web of Science ®Google Scholar
• Schmidt, L., Duh F. M., Chen F., Kishida T., Glenn G., Choyke P., Scherer S. W., Zhuang Z., Lubensky I., Dean M., Allikmets R., Chidambaram A., Bergerheim U. R., Feltis J. T., Casadevall C., Zamarron A., Bernues M., Richard S., Lips C. J., Walther M. M., Tsui L. C., Geil L., Orcutt M. L., Stackhouse T., Zbar B., et al. 1997. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 16:68–73.
   PubMed Web of Science ®Google Scholar
• Stoker, M., and Perryman M.. 1985. An epithelial scatter factor released by embryo fibroblasts. J. Cell Sci. 77:209–223.
   PubMed Web of Science ®Google Scholar
• Taher, T. E., Tjin E. P., Beuling E. A., Borst J., Spaargaren M., and Pals S. T.. 2002. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination. J. Immunol. 169:3793–3800.
   PubMed Web of Science ®Google Scholar
• Tikhomirov, O., and Carpenter G.. 2001. Caspase-dependent cleavage of ErbB-2 by geldanamycin and staurosporin. J. Biol. Chem. 276:33675–33680.
   PubMedGoogle Scholar
• Tulasne, D., Paumelle R., Weidner K. M., Vandenbunder B., and Fafeur V.. 1999. The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering. Mol. Biol. Cell 10:551–565.
   PubMed Web of Science ®Google Scholar
• Uehara, Y., Minowa O., Mori C., Shlota K., Kuno J., Noda T., and Kitamura N.. 1995. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373:702–705.
   PubMed Web of Science ®Google Scholar
• Vigna, E., Gramaglia D., Longati P., Bardelli A., and Comoglio P. M.. 1999. Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET. Oncogene 18:4275–4281.
   PubMedGoogle Scholar
• Villa-Moruzzi, E., Puntoni F., Bardelli A., Vigna E., De Rosa S., and Comoglio P. M.. 1998. Protein tyrosine phosphatase PTP-S binds to the juxtamembrane region of the hepatocyte growth factor receptor Met. Biochem. J. 336:235–239.
   PubMedGoogle Scholar
• Wang, X., DeFrances M. C., Dai Y., Pediaditakis P., Johnson C., Bell A., Michalopoulos G. K., and Zarnegar R.. 2002. A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol. Cell 9:411–421.
   PubMed Web of Science ®Google Scholar
• Weidner, K. M., Dicesare S., Sachs M., Brinkmann V., Behrens J., and Birchmeier W.. 1996. Interaction between gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 384:173–176.
   PubMed Web of Science ®Google Scholar
• Weidner, K. M., Hartmann G., Naldini L., Comoglio P. M., Sachs M., Fonatsch C., Rieder H., and Birchmeier W.. 1993. Molecular characteristics of HGF-SF and its role in cell motility and invasion. EXS 65:311–328.
   PubMedGoogle Scholar
• Weidner, K. M., Sachs M., and Birchmeier W.. 1995. Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells. Proc. Natl. Acad. Sci. USA 92:2597–2601.
   PubMedGoogle Scholar
• Widmann, C., Gerwins P., Johnson N. L., Jarpe M. B., and Johnson G. L.. 1998. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol. Cell. Biol. 18:2416–2429.
   PubMed Web of Science ®Google Scholar
• Yo, Y., Morishita R., Nakamura S., Tomita N., Yamamoto K., Moriguchi A., Matsumoto K., Nakamura T., Higaki J., and Ogihara T.. 1998. Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells. Kidney Int. 54:1128–1138.
   PubMed Web of Science ®Google Scholar